Turnstone Biologics Overview
- Founded
-
2015

- Status
-
Private
- Employees
-
123

- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$80M
- Investors
-
19
Turnstone Biologics General Information
Description
Developer of viral immunotherapies designed for cancer immunotherapies to improve survival. The company's immunotherapies combine a bio-selected and engineered oncologic virus to directly lyse tumors with a potent vaccine technology to drive tumor-antigen-specific T-cell responses, enabling bio-medical professionals to generate immune responses, treat cancer and modulate the tumor environment.
Contact Information
Website
www.turnstonebio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Drug Delivery
Primary Office
- 9310 Athena Circle
- Suite 300
- La Jolla, CA 92037
- United States
+1 (347) 000-0000
Turnstone Biologics Timeline
Turnstone Biologics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Later Stage VC (Series D) | 14-Jul-2021 | $80M | 00000 | Completed | Pre-Clinical Trials | |
5. Later Stage VC | 19-Dec-2019 | 00000 | 00000 | Completed | Pre-Clinical Trials | |
4. Later Stage VC (Series C) | 04-Jan-2019 | 0000 | 000.00 | Completed | Startup | |
3. Early Stage VC (Series B) | 02-Nov-2016 | 000.00 | 000.00 | Completed | Startup | |
2. Early Stage VC (Series A) | 28-Oct-2015 | $11.3M | $11.3M | Completed | Startup | |
1. Early Stage VC | 04-May-2015 | Completed | Startup |
Turnstone Biologics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of viral immunotherapies designed for cancer immunotherapies to improve survival. The company's immunotherapie
Biotechnology
La Jolla, CA
123
As of 2022
00000
00000000000
00000
Turnstone Biologics Competitors (54)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Centrose | Venture Capital-Backed | Middleton, WI | 00 | 000.00 | 0000000000 0 | 000.00 |
0000 000000 | Venture Capital-Backed | South San Francisco, CA | 00 | 00000 | 00000000000 | 00000 |
000000 | Venture Capital-Backed | Rochester, MN | 00 | 00000 | 00000000000 | 00000 |
00000000 | Venture Capital-Backed | Watertown, MA | 00 | 0000 | 00000000000 | 0000 |
000000 000000000 | Angel-Backed | New York, NY | 00000 | 0000000000 | 00000 |
Turnstone Biologics Patents
Turnstone Biologics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3152796-A1 | Methods for inducing an immune response against neoantigens | Pending | 27-Aug-2019 | 00000000000 | |
EP-4021470-A2 | Methods for inducing an immune response against neoantigens | Pending | 27-Aug-2019 | 00000000000 | |
US-20220305099-A1 | Methods for inducing an immune response against neoantigens | Pending | 27-Aug-2019 | 00000000000 | |
JP-2022514420-A | Modified orthopox viral vector | Pending | 21-Dec-2018 | 00000000000 | |
EP-3898998-A4 | Modified orthopoxvirus vectors | Pending | 21-Dec-2018 | C07K16/2818 | 0 |
Turnstone Biologics Executive Team (16)
Turnstone Biologics Board Members (12)
Name | Representing | Role | Since |
---|---|---|---|
Ben Auspitz | F-Prime Capital | Board Member | 000 0000 |
Bradley Bolzon Ph.D | Versant Ventures | Board Member | 000 0000 |
Jerel Davis Ph.D | Versant Ventures | Chairman | 000 0000 |
Kanya Rajangam Ph.D | Self | Board Member | 000 0000 |
Mike Burgess Ph.D | Turnstone Biologics | Interim Chief Medical Officer, Executive Director & Board Member | 000 0000 |
Turnstone Biologics Signals
Turnstone Biologics Investors (19)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
CaaS Capital Management | Hedge Fund | Minority | 000 0000 | 000000 0 | |
Eventide Asset Management | Asset Manager | Minority | 000 0000 | 000000 0 | |
JM Family Enterprises | Corporation | Minority | 000 0000 | 000000 0 | |
Northleaf Capital Partners | Limited Partner | Minority | 000 0000 | 000000 0 | |
PFM Health Sciences | Hedge Fund | Minority | 000 0000 | 000000 0 |
Turnstone Biologics Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000 00000000 | 20-Jan-2021 | 0000000000 | Biotechnology | 00000 000 |